The Corporate Venture Capital (CVC) arm of a global pharmaceutical company wanted to analyse a specific key APAC market to assess both the macro and micro-environment for Real World Data and Real Word Evidence to inform corporate strategy and prioritise key ventures for further engagement. By utilising Galen Growth's proven PlayBook methodology, we enabled our client to fully understand the RWD and RWE innovation environment and readiness to enable the identification and prioritisation of Digital Health ventures with the right capabilities and achievements. Further prioritisation driven by Deep Dive analysis of select ventures, to map their operating model, leading to direct engagement with their leadership team. The examination covered 1 key therapeutic area in 1 key APAC country. We screened 15 ventures and, in collaboration with our client, shortlisted 7.
The data, intel and insights from this comprehensive analysis allowed our investor client to better understand the digital health landscape of this key APAC market, identify “ready-made” RWE integrated solutions and develop appropriate scenarios / options for potential “integrated solutions” models where these are potentially complimentary.
|Number of countries||1|
|Number of therapeutic areas||1|
|Number of ventures screened||15|
|Number of ventures shortlisted||7|
Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth